Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.

@article{Myers2011OralPA,
  title={Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.},
  author={Gavin M Myers and Kenneth H. Mayer},
  journal={AIDS patient care and STDs},
  year={2011},
  volume={25 2},
  pages={
          63-71
        }
}
This article reviews the status of current research evaluating oral preexposure prophylaxis (PrEP) for prevention of HIV infection in high-risk populations. In animal model studies, the use of antiretrovirals has been shown to be effective in preventing HIV acquisition. Early-phase PrEP studies have established safety in humans. Currently, more than 20,000 men and women will soon be enrolled in studies of oral or topical chemoprophylaxis, testing a variety of drug delivery methods including… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 34 CITATIONS

Attitudes toward HIV pre-exposure prophylaxis among men who have sex with men in western China.

  • AIDS patient care and STDs
  • 2013
VIEW 10 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Couples Living with HIV.

  • Journal of the International Association of Providers of AIDS Care
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

A cost-effectiveness analysis of HIV preexposure prophylaxis for men who have sex with men in Australia.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2014
VIEW 1 EXCERPT
CITES BACKGROUND